Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis
- PMID: 1908085
- PMCID: PMC52223
- DOI: 10.1073/pnas.88.16.7011
Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis
Abstract
The expression of interleukin (IL) 2, IL-4, IL-10, and interferon gamma (IFN-gamma) by lymphocyte subsets was examined during infection of resistant C57BL/6 and susceptible BALB/c mice with the protozoan parasite Leishmania major. CD4+ and CD8+ T lymphocytes and B lymphocytes were isolated from the lymph nodes draining infectious lesions, and their RNA was examined for lymphokine transcripts. Distinct patterns of CD4+ cell cytokine expression were apparent: C57BL/6 CD4+ cells contained IFN-gamma and IL-2 mRNA, whereas BALB/c CD4+ cells expressed IL-4 and IL-10 message. CD8+ cells contributed little lymphokine expression during disease, but B cells were a major source of IL-2 mRNA in both strains of mice. BALB/c mice made resistant by treatment with anti-CD4 antibody at the time of infection repopulated lymph nodes with CD4+ cells that expressed IL-2 and IFN-gamma. Protective treatment with anti-IL-4 antibody in vivo also resulted in the appearance of CD4+ cells with increased IFN-gamma and diminished IL-4 and IL-10 expression. These data establish CD4+ cells as the primary source of IFN-gamma in healing mice and of IL-4 and IL-10 during progressive infection and confirm that the spectral extremes of this disease are characterized by the presence of CD4+ cells expressing Th1 or Th2 phenotypes in vivo.
Similar articles
-
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.J Exp Med. 1989 Jan 1;169(1):59-72. doi: 10.1084/jem.169.1.59. J Exp Med. 1989. PMID: 2521244 Free PMC article.
-
Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.J Immunol. 1992 Oct 15;149(8):2715-21. J Immunol. 1992. PMID: 1357029
-
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.J Immunol. 1991 Nov 1;147(9):3149-55. J Immunol. 1991. PMID: 1833466
-
The development of effector T cell subsets in murine Leishmania major infection.Ciba Found Symp. 1995;195:110-7; discussion 117-22. doi: 10.1002/9780470514849.ch8. Ciba Found Symp. 1995. PMID: 8724833 Review.
-
Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection.Res Immunol. 1991 Jan;142(1):28-32. doi: 10.1016/0923-2494(91)90007-6. Res Immunol. 1991. PMID: 1829257 Review. No abstract available.
Cited by
-
T helper phenotype and genetic susceptibility in experimental Lyme disease.J Exp Med. 1995 Mar 1;181(3):1251-4. doi: 10.1084/jem.181.3.1251. J Exp Med. 1995. PMID: 7869043 Free PMC article.
-
Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.J Exp Med. 1993 Dec 1;178(6):2123-30. doi: 10.1084/jem.178.6.2123. J Exp Med. 1993. PMID: 7902409 Free PMC article.
-
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.J Exp Med. 1997 Oct 6;186(7):1137-47. doi: 10.1084/jem.186.7.1137. J Exp Med. 1997. PMID: 9314562 Free PMC article.
-
Induction of TH1- and TH2-associated cytokine mRNA in mouse bladder following intravesical growth of the murine bladder tumor MB49 and BCG immunotherapy.Cancer Immunol Immunother. 1994 Dec;39(6):401-6. doi: 10.1007/BF01534428. Cancer Immunol Immunother. 1994. PMID: 8001028 Free PMC article.
-
In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis.Infect Immun. 1996 Dec;64(12):5248-54. doi: 10.1128/iai.64.12.5248-5254.1996. Infect Immun. 1996. PMID: 8945573 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials